Skip to Main Content

Paper Details

Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer.
Eur Urol
65
2016
Author NameAffiliation
Roberta FerraldeschiThe Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
Zafeiris ZafeiriouThe Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
Niven MehraThe Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
Raquel Perez-LopezThe Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
Joaquin MateoThe Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
Nina TunariuThe Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
Gerhardt AttardThe Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
Johann S de BonoThe Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
  • 1 - 8

Datasets